7-Aug-2026
Hinge Health, Inc. Class A Posts Powerful Earnings
TipRanks (Wed, 5-Aug 8:23 PM ET)
Hinge Health Lifts Revenue Forecast as Cylinder Health Deal Expands its Care Platform
Market Chameleon (Wed, 5-Aug 7:51 AM ET)
TipRanks (Wed, 5-Aug 10:10 AM ET)
Hinge Health Buy Rating Reaffirmed as Growth Accelerates and Price Target Raised from $76 to $97
TipRanks (Wed, 5-Aug 4:56 AM ET)
Hinge Health Earns Buy Rating on Robust Double-Digit Growth and Expanding Commercial Footprint
TipRanks (Tue, 4-Aug 6:35 PM ET)
Hinge Health Posts Record Q2 Results, Raises Outlook
TipRanks (Tue, 4-Aug 5:14 PM ET)
Hinge Health, Inc. Non-GAAP EPS of $0.59 misses by $0.02, revenue of $213M beats by $11.51M
Seeking Alpha News (Tue, 4-Aug 4:22 PM ET)
Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care
Business Wire (Tue, 4-Aug 4:05 PM ET)
Business Wire (Tue, 4-Aug 4:05 PM ET)
Evercore ISI Reaffirms Their Buy Rating on Hinge Health, Inc. Class A (HNGE)
TipRanks (Tue, 4-Aug 11:29 AM ET)
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
Hinge Health Class A trades on the NYSE stock market under the symbol HNGE.
As of August 7, 2026, HNGE stock price climbed to $89.33 with 2,264,313 million shares trading.
HNGE has a beta of 1.22, meaning it tends to be more sensitive to market movements. HNGE has a correlation of 0.05 to the broad based SPY ETF.
HNGE has a market cap of $6.91 billion. This is considered a Mid Cap stock.
Last quarter Hinge Health Class A reported $213 million in Revenue and $.59 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.04.
The top ETF exchange traded funds that HNGE belongs to (by Net Assets): VTI, VB, IWM, VBR, IWO.
HNGE has outperformed the market in the last year with a price return of +47.5% while the SPY ETF gained +23.4%. HNGE has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +62.9% and +16.5%, respectively, while the SPY returned +5.6% and +4.8%, respectively.
HNGE support price is $77.64 and resistance is $82.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HNGE shares will trade within this expected range on the day.